Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
1.53 USD | -10.00% | -29.49% | -51.74% |
Kurzporträt
Mitarbeiterzahl: 12
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Mark Dybul
CEO | Chief Executive Officer | 60 | 23.01.18 |
Lester Russell
CTO | Chief Tech/Sci/R&D Officer | - | 21.08.23 |
Greg Duczynski
CTO | Chief Tech/Sci/R&D Officer | - | 01.01.16 |
Joseph R. Cohen
CTO | Chief Tech/Sci/R&D Officer | - | - |
François Binette
COO | Chief Operating Officer | - | 20.04.22 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Gregg Alton
BRD | Director/Board Member | 58 | 01.01.20 |
Avram Miller
BRD | Director/Board Member | - | 11.10.23 |
James Sapirstein
BRD | Director/Board Member | 63 | 06.03.18 |
Director/Board Member | 60 | 04.10.23 | |
Director/Board Member | 78 | 04.10.23 | |
Carol Brosgart
BRD | Director/Board Member | 72 | 27.12.19 |
Rene Sindlev
CHM | Chairman | 61 | 18.01.11 |
Mark Dybul
CEO | Chief Executive Officer | 60 | 23.01.18 |
Jayne McNicol
BRD | Director/Board Member | 57 | 25.05.21 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 143 668 372 | 105 978 359 ( 73,77 %) | 0 | 73,77 % |
Aktie B | 0 | 561 010 | 0 | 0 |
Unternehmenskontakt
Renovaro, Inc.
1927 Paseo Rancho Castillo
90032-2012, Los Angeles
+45 39 17 98 40
http://www.enochianbio.comSektor
% 1. Jan. | Kap. | |
---|---|---|
-51.74% | 220 Mio. | |
-2.31% | 103 Mrd. | |
+0.56% | 95.28 Mrd. | |
+1.69% | 22.15 Mrd. | |
-17.37% | 21.02 Mrd. | |
-9.30% | 18.15 Mrd. | |
-41.01% | 16.74 Mrd. | |
-14.85% | 16.05 Mrd. | |
+3.21% | 13.68 Mrd. | |
+33.54% | 12.17 Mrd. |
- Börse
- Aktien
- A2PBYQ Aktie
- Unternehmen Renovaro Inc.